ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
TidalSense, a Cambridge, UK-based AI respiratory diagnostics company, secured $19 million to commercialize its non-invasive COPD testing. The round brings total funding to $40 million and includes Cross-Border Impact Ventures, BGF, Airstream Capital, and Foresight Group. Funds will support UK, Ireland, Europe, and US market entry.
Tap to vote and see what everyone thinks.
Summary by ByteBrief